News
Immune Cell Therapy Market Size BURLINGAME, CA, UNITED STATES, June 19, 2025 /EINPresswire / --The latest research study released by C ...
Taiwan Cell Manufacturing Company (tcmc), a leading Contract Development and Manufacturing Organization (CDMO) in cell and ...
APEX shows Tremfya is the first IL-23 inhibitor to slow joint damage in psoriatic arthritis, offering early, multi-domain ...
The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.
Gene therapies have ridden investor mania to huge valuations but commercialization challenges have pushed market caps to the ...
The startup, which is backed by the venture arms of Sanofi, Roche and Novartis, is using dual adeno-associated viruses to help overcome the packaging constraints of current genetic medicines.
Bio-Techne’s TECH GMP reagents, including GMP proteins and small molecules, remain a cornerstone of its cell therapy offering ... biomarkers at an attomolar level from sub-microliter sample volume.
It’s back to the drawing board for bluebird bio and its discussions with NICE, which has rejected its beta thalassaemia gene therapy Zynteglo ... came from a small sample of patients and is ...
When I started dating again after my first big breakup, I thought the key to finding love was being as palatable as possible.
BIO was as busy as ever in Boston this year. With more to come soon, here are a few initial thoughts on three events I ...
Discover Cabaletta Bio's promising CAR T-cell therapy for autoimmune diseases! Durable efficacy, FDA support, and clinical ...
FDA Commissioner Martin Makary, MD, shared his vision for a “New FDA” with biopharma leaders attending BIO in Boston.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results